IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.28% | 13.29% | 10.55% | 3.56% | 5.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.28% | 13.29% | 10.55% | 3.56% | 5.84% |
| Cost of Revenue | 12.73% | 11.17% | 7.88% | 1.08% | 2.18% |
| Gross Profit | 15.33% | 14.65% | 12.21% | 5.11% | 8.46% |
| SG&A Expenses | 6.14% | 11.31% | 8.97% | 2.61% | 9.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.59% | 11.72% | 8.57% | 2.52% | 5.53% |
| Operating Income | 24.04% | 16.77% | 14.68% | 5.88% | 6.68% |
| Income Before Tax | 19.73% | 15.34% | 39.87% | 4.94% | 6.98% |
| Income Tax Expenses | 46.12% | 6.20% | 22.61% | 12.53% | -10.87% |
| Earnings from Continuing Operations | 14.82% | 17.94% | 44.61% | 3.01% | 11.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.82% | 17.94% | 44.61% | 3.01% | 11.12% |
| EBIT | 24.04% | 16.77% | 14.68% | 5.88% | 6.68% |
| EBITDA | 23.00% | 15.81% | 14.36% | 6.61% | 7.40% |
| EPS Basic | 17.62% | 21.19% | 48.60% | 5.27% | 12.81% |
| Normalized Basic EPS | 26.25% | 18.52% | 16.16% | 7.24% | 8.60% |
| EPS Diluted | 17.88% | 21.43% | 48.77% | 5.34% | 13.41% |
| Normalized Diluted EPS | 26.40% | 18.75% | 16.39% | 7.55% | 8.78% |
| Average Basic Shares Outstanding | -2.38% | -2.68% | -2.68% | -2.14% | -1.49% |
| Average Diluted Shares Outstanding | -2.49% | -2.87% | -2.88% | -2.42% | -1.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |